Donor predictors of allograft use and recipient outcomes after heart transplantation

Circulation: Heart Failure

Volumn 6, Issue 2, 2013, Pages 300-309

  Khush, Kiran K ^a   Menza, Rebecca ^b   Nguyen, John ^c   Zaroff, Jonathan G ^d   Goldstein, Benjamin A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^c California Transplant Donor Network   (United States)

^d DIVISION OF RESEARCH   (United States)

Author keywords

Heart transplantation; Organ donor; Transplant outcomes; Transplant recipients

Indexed keywords

TROPONIN;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DONOR SELECTION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE WALL MOTION; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; ADOLESCENT; AGED; DONOR; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; CALIFORNIA; DONOR SELECTION; FEMALE; HEART TRANSPLANTATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

MLCS; MLOWN;

EID: 84877299055     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.000165     Document Type: Article

References (40)

1. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant. 2012;31:117-126.
2. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report-2011. J Heart Lung Transplant. 2011;30:1078-1094.
3. Costanzo MR. Selection and treatment of candidates for heart transplantation. Semin Thorac Cardiovasc Surg. 1996;8:113-125.
4. Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D'Alessandro A, Dec GW, Edwards NM, Higgins RS, Jeevanandum V, Kauffman M, Kirklin JK, Large SR, Marelli D, Peterson TS, Ring WS, Robbins RC, Russell SD, Taylor DO, Van Bakel A, Wallwork J, Young JB. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation. 2002;106:836-841.
5. Sheehy E, Conrad SL, Brigham LE, Luskin R, Weber P, Eakin M, Schkade L, Hunsicker L. Estimating the number of potential organ donors in the United States. N Engl J Med. 2003;349:667-674.
6. Goland S, Czer LS, Kass RM, Siegel RJ, Mirocha J, De Robertis MA, Lee J, Raissi S, Cheng W, Fontana G, Trento A. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. J Am Coll Cardiol. 2008;51:1214-1220.
7. Laks H, Marelli D, Fonarow GC, Hamilton MA, Ardehali A, Moriguchi JD, Bresson J, Gjertson D, Kobashigawa JA; UCLA Heart Tranplant Group. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg. 2003;125:49-59.
8. Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM, Rogers JG, Lodge AJ, Milano CA. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006;114(1 suppl):I27-I32.
9. Ott GY, Herschberger RE, Ratkovec RR, Norman D, Hosenpud JD, Cobanoglu A. Cardiac allografts from high-risk donors: excellent clinical results. Ann Thorac Surg. 1994;57:76-81; discussion 81.
10. Young JB, Naftel DC, Bourge RC, Kirklin JK, Clemson BS, Porter CB, Rodeheffer RJ, Kenzora JL. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994;13:353-64; discussion 364.
11. Stehlik J, Feldman DS, Brown RN, VanBakel AB, Russel SD, Ewald GA, Hagan ME, Folsom J, Kirklin JK; Cardiac Transplant Research Database Group. Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis. J Heart Lung Transplant. 2010;29:291-298.
12. Smits JM, De Pauw M, de Vries E, Rahmel A, Meiser B, Laufer G, Zuckermann A. Donor scoring system for heart transplantation and the impact on patient survival. J Heart Lung Transplant. 2012;31:387-397.
13. Al-Khaldi A, Oyer PE, Robbins RC. Outcome analysis of donor gender in heart transplantation. J Heart Lung Transplant. 2006;25:461-468.
14. Zeier M, Döhler B, Opelz G, Ritz E. The effect of donor gender on graft survival. J Am Soc Nephrol. 2002;13:2570-2576.
15. Tsai FC, Marelli D, Bresson J, Gjertson D, Kermani R, Ardehali A, Esmailian F, Hamilton M, Fonarow GC, Moriguchi J, Plunkett M, Hage A, Tran J, Kobashigawa JA, Laks H. Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs. Am J Transplant. 2002;2:539-545.
16. Bryan CF, Mitchell SI, Borkon AM, Curtis J, Demmy T, Estep TH, Moran J. Influence of donor gender on patient mortality after heart transplantation. Transplant Proc. 1996;28:149-151.
17. Sharples LD, Caine N, Mullins P, Scott JP, Solis E, English TA, Large SR, Schofield PM, Wallwork J. Risk factor analysis for the major hazards following heart transplantation-rejection, infection, and coronary occlusive disease. Transplantation. 1991;52:244-252.
18. Singhal AK, Sheng X, Drakos SG, Stehlik J. Impact of donor cause of death on transplant outcomes: UNOS registry analysis. Transplant Proc. 2009;41:3539-3544.
19. Cohen O, De La Zerda DJ, Beygui R, Hekmat D, Laks H. Donor brain death mechanisms and outcomes after heart transplantation. Transplant Proc. 2007;39:2964-2969.
20. Sobieszczaska-Maek M, Zieliski T, Korewicki J. The influence of donor-related factors on the frequency of acute cellular rejection by the recipient in the first year following heart transplantation. Ann Transplant. 2007;12:38-43.
21. Houser SL, MacGillivray T, Aretz HT. The impact of cocaine on the donor heart: a case report. J Heart Lung Transplant. 2000;19:609-611.
22. Freimark D, Czer LS, Admon D, Aleksic I, Valenza M, Barath P, Harasty D, Queral C, Azen CG, Blanche C. Donors with a history of cocaine use: effect on survival and rejection frequency after heart transplantation. J Heart Lung Transplant. 1994;13:1138-1144.
23. Brieke A, Krishnamani R, Rocha MJ, Li W, Patten RD, Konstam MA, Patel AR, Udelson JE, Denofrio D. Influence of donor cocaine use on outcome after cardiac transplantation: analysis of the United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant. 2008;27:1350-1352.
24. Tsao CI, Chen RJ, Chou NK, Ko WJ, Chi NH, Yu HY, Chen YS, Chen SC, Wang SS. The influence of donor characteristics on survival after heart transplantation. Transplant Proc. 2008;40:2636-2637.
25. Potapov EV, Ivanitskaia EA, Loebe M, Möckel M, Müller C, Sodian R, Meyer R, Hetzer R. Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure. Transplantation. 2001;71:1394-1400.
26. Potapov EV, Wagner FD, Loebe M, Ivanitskaia EA, Müller C, Sodian R, Jonitz B, Hetzer R. Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation. Int J Cardiol. 2003;92:163-167.
27. Khush KK, Menza RL, Babcock WD, Zaroff JG. Donor cardiac troponin I levels do not predict recipient survival after cardiac transplantation. J Heart Lung Transplant. 2007;26:1048-1053.
28. Zaroff JG, Babcock WD, Shiboski SC. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant. 2003;22:334-337.
29. Aziz S, Soine LA, Lewis SL, Kruse AP, Levy WC, Wehe KM, Fishbien DP, Allen MD. Donor left ventricular hypertrophy increases risk for early graft failure. Transpl Int. 1997;10:446-450.
30. Marelli D, Laks H, Fazio D, Moore S, Moriguchi J, Kobashigawa J. The use of donor hearts with left ventricular hypertrophy. J Heart Lung Transplant. 2000;19:496-503.
31. Brieman L. Random forests. Machine Learning. 2001;45:5-32.
32. Chen JM, Sinha P, Rajasinghe HA, Suratwala SJ, McCue JD, McCarty MJ, Caliste X, Hauff HM, John R, Edwards NM. Do donor characteristics really matter? Short- and long-term impact of donor characteristics on recipient survival, 1995-1999. J Heart Lung Transplant. 2002;21: 608-610.
33. Weiss ES, Allen JG, Kilic A, Russell SD, Baumgartner WA, Conte JV, Shah AS. Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation. J Heart Lung Transplant. 2012;31:266-273.
34. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.
35. Drakos SG, Kfoury AG, Kotter JR, Reid BB, Clayson SE, Selzman CH, Stehlik J, Fisher PW, Merida M 3rd, Eckels DD, Brunisholz K, Horne BD, Stoker S, Li DY, Renlund DG. Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of postimplantation human leukocyte antigen-allosensitization. J Heart Lung Transplant. 2009;28:838-842.
36. Arnaoutakis GJ, George TJ, Kilic A, Weiss ES, Russell SD, Conte JV, Shah AS. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. J Thorac Cardiovasc Surg. 2011;142:1236-1245, 1245 e1231.
37. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel AN. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. J Thorac Cardiovasc Surg. 2010;140:169-173.
38. Jeevanandam V, Furukawa S, Prendergast TW, Todd BA, Eisen HJ, Mc- Clurken JB. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg. 1996;62:1268-1275.
39. Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transpl Int. 2008;21:113-125.
40. Shah MR, Starling RC, Schwartz Longacre L, Mehra MR; Working Group Participants. Heart transplantation research in the next decade- A goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working Group. J Am Coll Cardiol. 2012;59:1263-1269.